Status:

RECRUITING

Patient-reported Outcome and Patient-reported Experience After Status Epilepticus

Lead Sponsor:

Versailles Hospital

Conditions:

Patient Reported Outcomes

Patient Satisfaction

Eligibility:

All Genders

18+ years

Brief Summary

Status epilepticus (SE) is a common life-threatening neurological emergency in which prolonged or multiple closely spaced seizures can result in long-term impairments. SE remains associated with consi...

Eligibility Criteria

Inclusion

  • Adults 18 years old or older
  • Patients previously included in the ICTAL registry (Status Epilepticus cohort NCT03457831)
  • Survivors after ICU management for Status Epilepticus More than 3 months and less than 5 years after ICU discharge

Exclusion

  • Legal guardianship
  • Opposition to participate
  • Unread and unwritten French language
  • Patient not affiliated to a Social Security system

Key Trial Info

Start Date :

May 25 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

145 Patients enrolled

Trial Details

Trial ID

NCT06100978

Start Date

May 25 2024

End Date

July 1 2026

Last Update

November 5 2024

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

CH d'Angoulême

Angoulême, France

2

CH de Béthune

Béthune, France

3

Hôpital Beaujon

Clichy, France

4

Hôpital Henri Mondor

Créteil, France